Key Points
Aditya Arora, Adlytick, says: I would like to maintain a cautious view on the market because it is not a broad-based rally..
Smallcaps are correcting and on the other hand, safe havens like gold and bullion are doing well and pharma is also doing well..
I think money is to be made on the long side on the pharma space and on the short side on high beta counters...
Aditya Arora: As you rightly said, the market is lacking momentum and is lacking some strength to inch to newer highs although certain pockets are doing well, like Nifty PSE basket, the energy basket..
Aditya Arora: I think all the pharma counters are doing well..
You might be interested in
Nifty hits a new record, F&O rollovers signal momentum
01, Dec, 23Market momentum expected to continue as demand outstrips supply and retail and HNI appetite increases.
How will a BJP win in Lok Sabha polls impact markets? What brokerages predict
28, May, 24The stock market has seen a rally during the ongoing general elections with the Sensex and Nifty reaching an all-time high on Monday in early trading.
Aditya Arora is bullish on Nifty Pharma, sees last leg of rally in high beta counters post Budget
31, Jan, 24Aditya Arora is tracking Nifty Pharma and mentions good moves in Cipla, Dr Lal Path Lab, and Metropolis. The chart structure of many pharma counters has improved. On the flip side, many financials or cyclical stocks appear to be topping out. Indiabulls Housing Finance is breaking out with volume support. Aditya Arora recommends buying it at Rs 215 with a stop loss at Rs 190 and a target of Rs 230 to 250.